Recent Finacing
Recent Raise
Re-Vana Therapeutics develops photo-crosslinked biodegradable sustained‑release ophthalmic drug‑delivery platforms (EyeLief, OcuLief) to deliver biologics and small molecules for retinal and ocular diseases, based in Belfast and Tampa.
